AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Alanine

9 registrations across 1 African market— 3 active

Markets with Alanine

Recent registrations

Brand / ProductMarketHolderStatusExpires
AMINOMIX 1🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdsuspendedMay 2025
AMINOVENOUS N PAED 6%🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdsuspendedJan 2023
INTRAMED AMINO ACIDS SOLUTION 5,5%🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
INTRAMED AMINO ACIDS SOLUTION 8,5% WITH ELECTROLYTES🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
INTRAMED AMINO ACIDS SOLUTION 8,5%🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
INTRAMED AMINO ACIDS SOLUTION 5,5% WITH ELECTROLYTES🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
NUMETA G16E🇿🇦South AfricaBaxter Healthcare South Africa (Pty) LtdactiveJan 1900
NUMETA G19E🇿🇦South AfricaBaxter Healthcare South Africa (Pty) LtdactiveJan 1900
NUMETA G13E🇿🇦South AfricaBaxter Healthcare South Africa (Pty) LtdactiveJan 1900

Alanine in Africa — Regulatory Overview

Alanine is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 3 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.